Skip to main content
. 2018 Nov 12;18:1101. doi: 10.1186/s12885-018-5007-0

Table 3.

Literature Overview

Source Period Stage AC SCC Sign. AC - SCC
n 5y OS n 5yOS
Early
 Hopkins et al. [4] 1970–1985 I 124 0.6 370 0.9 X −0.3
 Shingleton et al. [30] 1984–1990 I 174 0.84 1136 0.84 0
 Couvreur et al.a 2005–2015 IA-1B1 20 1 52 0.89 0.11
 Teke et al. [8] 1996–2000 IA-IIB 33 0.77 218 0.73 0.04
 Ayhan et al. [31] 1980–1997 IB 67 0.84 454 0.88 − 0.04
 Eifel et al. [32] 1960–1989 IB 229 0.72 1538 0.81 X − 0.09
 Nakanishi et al. [34] 1976–1995 IB 104 0.88 405 0.96 X −0.08
 Galic et al. [3] 1998–2005 IB1 1094 0.85 3214 0.88 −0.03
 Shimada et al. [6] 1997–2003 IB1 184 0.92 258 0.95 −0.03
Advanced
 Galic et al. [3] 1998–2005 IB2 343 0.68 1701 0.69 −0.01
 Shimada et al. [6] 1997–2003 IB2 39 0.76 67 0.74 0.01
 Irie et al. [33] 1981–1996 IB-IIA 50 0.78 198 0.92 −0.14
 Shimada et al. [6] 1997–2003 IB-IIB 280 0.87 540 0.83 0.04
 Hopkins et al. [4] 1970–1985 II 40 0.47 186 0.62 X −0.15
 Shingleton et al. [30] 1984–1990 II 102 0.57 1073 0.67 X −0.11
 Galic et al. [3] 1998–2005 IIA 202 0.46 1488 0.58 X −0.13
 Shimada et al. [6] 1997–2003 IIA 11 0.55 83 0.87 X −0.33
 Galic et al. [3] 1998–2005 IIB 424 0.46 3754 0.55 X −0.09
 Katanyoo et al. [7] 1980–1997 IIB 85 0.72 170 0.71 0.01
 Shimada et al. [6] 1997–2003 IIB 46 0.63 132 0.79 X −0.16
 Couvreur et al.a 2005–2015 IB2-IVA 16 0.88 91 0.63 0.25
 Hopkins et al. [4] 1970–1985 III 25 0.08 114 0.36 X −0.28
 Shingleton et al. [30] 1984–1990 III 47 0.3 672 0.4 −0.1
 Galic et al. [3] 1998–2005 IIIA 80 0.16 695 0.34 X −0.18
 Galic et al. [3] 1998–2005 IIIB 238 0.2 2568 0.31 X −0.11
 Katanyoo et al. [7] 1995–2008 IIIB-IVA 56 0.41 112 0.47 −0.06
 Shingleton et al. [30] 1984–1990 IV 41 0.05 287 0.13 −0.08
 Galic et al. [3] 1998–2005 IVA 82 0.08 622 0.17 −0.09
 Galic et al. [3] 1998–2005 IVB 281 0.09 959 0.06 0.04

AC adenocarcinoma, SCC Squamous cell carcinoma, n number, 5yOS 5 year overall survival period: years of enrollment of patients, Sign significance with p-value < 0.05 (all significance levels lie between 0.01 and 0.05); AC-SCC: 5y survival data AC minus 5y survival data SCC resulting in a delta value

acurrent article